IL22 and liver disorder: We demonstrated that delivery of interleukin-22 following phage-mediated lysis decreases indicators of liver disease in a model of alcohol binge-fed mice (35), while phage-mediated release of interleukin-22 or interferon-β increased the survival of mice exposed to body irradiation (36, –, 39).